89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 108 filers reported holding 89BIO INC in Q4 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,008,326 | -31.3% | 518,674 | -15.7% | 0.00% | 0.0% |
| Q2 2023 | $11,657,415 | +63.5% | 615,167 | +31.4% | 0.00% | 0.0% |
| Q1 2023 | $7,130,549 | -15.1% | 468,191 | -29.1% | 0.00% | 0.0% |
| Q4 2022 | $8,400,833 | +273.4% | 659,924 | +69.8% | 0.00% | +100.0% |
| Q3 2022 | $2,250,000 | +712.3% | 388,580 | +351.5% | 0.00% | – |
| Q2 2022 | $277,000 | +4.9% | 86,061 | +22.9% | 0.00% | – |
| Q1 2022 | $264,000 | +97.0% | 70,036 | +583.6% | 0.00% | – |
| Q4 2021 | $134,000 | -42.7% | 10,245 | -18.2% | 0.00% | – |
| Q2 2021 | $234,000 | -59.9% | 12,525 | -49.1% | 0.00% | – |
| Q1 2021 | $583,000 | +162.6% | 24,631 | +170.8% | 0.00% | – |
| Q4 2020 | $222,000 | -63.0% | 9,095 | -60.2% | 0.00% | – |
| Q4 2019 | $600,000 | – | 22,836 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 11,416,948 | $216,351,165 | 4.08% |
| Orchard Capital Management, LLC | 542,879 | $10,287,557 | 3.46% |
| Artia Global Partners LP | 465,465 | $8,820,562 | 3.04% |
| Octagon Capital Advisors LP | 1,066,784 | $20,215,557 | 2.81% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,393,236 | $45,351,822 | 2.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 396,497 | $7,513,618 | 2.32% |
| Boxer Capital, LLC | 2,100,000 | $39,795 | 1.85% |
| Velan Capital Investment Management LP | 95,000 | $1,800,250 | 1.67% |
| Cormorant Asset Management, LP | 1,350,000 | $25,582,500 | 1.43% |
| Tri Locum Partners LP | 165,897 | $3,143,748 | 1.17% |